CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives


Autoria(s): Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew
Data(s)

2014

Formato

application/pdf

Identificador

http://boris.unibe.ch/67478/1/Seiten_4_aus%20SMW_Suppl-206.pdf

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Swiss medical weekly, 144(Suppl206), 3S-3S. EMH Schweizerischer �rzteverlag

doi:10.7892/boris.67478

urn:issn:1424-7860

Idioma(s)

eng

Publicador

EMH Schweizerischer �rzteverlag

Relação

http://boris.unibe.ch/67478/

Direitos

info:eu-repo/semantics/openAccess

Fonte

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Swiss medical weekly, 144(Suppl206), 3S-3S. EMH Schweizerischer �rzteverlag

Palavras-Chave #610 Medicine & health
Tipo

info:eu-repo/semantics/conferenceObject

info:eu-repo/semantics/publishedVersion

PeerReviewed